citiesrefa.blogg.se - Cdc guidance for vaccinated individuals

Cdc guidance for vaccinated individuals series#

Receipt of solid-organ transplant or an islet transplant and taking immunosuppressive therapy.

Hematologic malignancies associated with poor responses to COVID-19 vaccines regardless of current treatment status (e.g., chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia).

Active treatment for solid tumor and hematologic malignancies.

You may also be eligible for EVUSHELD TM, a medicine given by your healthcare provider every six months to help prevent you from getting COVID-19.Įxamples of medical conditions or treatments that may result in moderate to severe immunocompromise include but are not limited to:.You can self-attest to your moderately or severely immunocompromised status, which means you do not need any documentation of your status in order to receive COVID-19 vaccine doses you might be eligible to receive.Use CDC’s COVID-19 booster tool to learn if and when you can get boosters to stay up to date with your COVID-19 vaccines.

Cdc guidance for vaccinated individuals series#

CDC recommends that people with moderate or severe immunocompromise get an extra primary series dose if receiving the Moderna or Pfizer-BioNTech series.

One updated booster dose is recommended for all people ages 5 years and older, regardless of whether or not they are immunocompromised. CDC recommends everyone ages 5 years and older get an updated COVID-19 booster to help restore protection that has decreased since your last vaccine.As with vaccines for other diseases, you are protected best when you stay up to date with your COVID-19 vaccines as described below.

If you are moderately or severely immunocompromised (have a weakened immune system), you are at increased risk of severe COVID-19 illness and death. Additionally, your immune response to COVID-19 vaccination may not be as strong as in people who are not immunocompromised.